These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 175640)

  • 21. Antiviral response to herpes simplex virus type 1 in latent and active infection.
    Santiago J; Gomez B
    J Infect Dis; 1988 Apr; 157(4):817-9. PubMed ID: 2831287
    [No Abstract]   [Full Text] [Related]  

  • 22. Presence of herpes simplex virus-specific antigens in exfoliated cervical cells of virgins and sexually active women.
    Pacsa AS; Pejtsik B; Dorsits G; Kummerländer L
    Eur J Cancer (1965); 1977 Oct; 13(10):1197-9. PubMed ID: 200432
    [No Abstract]   [Full Text] [Related]  

  • 23. Immune destruction of virus-infected cells early in the infectious cycle.
    Shore SL; Cromeans TL; Romano TJ
    Nature; 1976 Aug; 262(5570):695-6. PubMed ID: 183139
    [No Abstract]   [Full Text] [Related]  

  • 24. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous dual infection of herpes simplex virus type 1 and Epstein-Barr virus in an immunocompetent patient.
    Akaboshi I; Hata A; Katsuki T; Matsuda I
    Pediatr Infect Dis J; 1988 Sep; 7(9):655-8. PubMed ID: 2845350
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of Western Blot Analysis to microneutralization for the detection of type-specific herpes simplex virus antibodies.
    Bernstein DI; Garratty E; Lovett MA; Bryson YJ
    J Med Virol; 1985 Mar; 15(3):223-30. PubMed ID: 2984325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract.
    Rebbapragada A; Wachihi C; Pettengell C; Sunderji S; Huibner S; Jaoko W; Ball B; Fowke K; Mazzulli T; Plummer FA; Kaul R
    AIDS; 2007 Mar; 21(5):589-98. PubMed ID: 17314521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell.
    Melewicz FM; Shore SL; Ades EW; Phillips DJ
    J Immunol; 1977 Feb; 118(2):567-73. PubMed ID: 65428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular immunity to herpes simplex virus in man. VII. K-cell activity to HSV1 infected target cells in disease.
    Russell AS; Essery G
    Cancer; 1977 Jul; 40(1):42-5. PubMed ID: 195708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental infection of mice with Herpes simplex virus].
    Rajcáni J
    Bratisl Lek Listy; 1971 Oct; 56(4):416-26. PubMed ID: 4334357
    [No Abstract]   [Full Text] [Related]  

  • 31. Nonvirion antigens produced by herpes simplex viruses 1 and 2.
    Tarro G; Sabin AB
    Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1032-6. PubMed ID: 4352219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpes simplex and herpes genitalis viruses in etiology of some human cancers.
    Sabin AB; Tarro G
    Proc Natl Acad Sci U S A; 1973 Nov; 70(11):3225-9. PubMed ID: 4361685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of herpes simplex virus in cervical and vulvar cancer.
    Melnick JL; Dreesman GR; Adam E; Kaufman R
    Dev Biol Stand; 1982; 52():87-94. PubMed ID: 6299862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of an in vitro keratinocyte model for use in the study of HSV specific cytotoxicity.
    Brice SL; Norris DA; Weston WL; Tedder DG; Lyons MB; Furukawa F; Huff JC
    J Invest Dermatol; 1988 May; 90(5):629-33. PubMed ID: 2452207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Herpes simplex virus antigens and antibodies: a survey of studies based on quantitative immunoelectrophoresis.
    Vestergaard BF
    Rev Infect Dis; 1980; 2(6):899-913. PubMed ID: 6164087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of the identification and titration of antibodies to herpes simplex viruses type 1 and type 2 in human sera.
    Plummer G
    Cancer Res; 1973 Jun; 33(6):1469-76. PubMed ID: 4352384
    [No Abstract]   [Full Text] [Related]  

  • 37. Detection of type-specific antibody to herpes simplex virus type 1 and 2 in human sera by complement-fixation tests.
    Skinner GR; Hartley CH; Whitney JE
    Arch Virol; 1976; 50(4):323-33. PubMed ID: 179502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Herpes simplex virus specific antibody determined by immunoblotting in cerebrospinal fluid of a patient with the Guillain-Barré syndrome.
    Bernsen HJ; Van Loon AM; Poels RF; Verhagen WI; Frenken CW
    J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):788-91. PubMed ID: 2545828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpesvirus-induced antigens in squamous-cell carcinoma in situ of the vulva.
    Kaufman RH; Dreesman GR; Burek J; Korhonen MO; Matson DO; Melnick JL; Powell KL; Purifoy DJ; Courtney RJ; Adam E
    N Engl J Med; 1981 Aug; 305(9):483-8. PubMed ID: 6265780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunity to tumors induced by herpes simplex virus in hamsters].
    Kosiakov PN; Posevaia TA; Kosiakova NP; Barinskiĭ IF
    Vopr Virusol; 1991; 36(1):40-4. PubMed ID: 1650065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.